Comorbidity Control Might Slow MS Activity 🔗 Access full article via Medscape NeurologyThe strong association in this meta-analysis, presented at the 2024 ECTRIMS annual meeting, were drawn from 15 multicenter phase 3 treatment trials with 16,794 participants. MDedge News Share:TwitterFacebookEmailRedditMoreLinkedInWhatsAppTelegramMastodon
